5UQH | pdb_00005uqh

Crystal Structure of the Catalytic Domain of the Inosine Monophosphate Dehydrogenase from Campylobacter jejuni in the complex with inhibitor p182


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free: 
    0.213 (Depositor), 0.214 (DCC) 
  • R-Value Work: 
    0.172 (Depositor), 0.174 (DCC) 
  • R-Value Observed: 
    0.174 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 5UQH

Ligand Structure Quality Assessment 


This is version 1.4 of the entry. See complete history

Literature

Role of the Mobile Active Site Flap in IMP Dehydrogenase Inhibitor Binding.

Wang, X.Rosenberg, M.M.Kim, Y.Maltseva, N.Cuny, G.D.Joachimiak, A.Kuzmic, P.Hedstrom, L.

(2025) ACS Infect Dis 11: 442-452

  • DOI: https://doi.org/10.1021/acsinfecdis.4c00636
  • Primary Citation Related Structures: 
    5UQF, 5UQG, 5UQH, 5URQ, 5UWX, 5UXE, 5UZC, 5UZE, 5UZS, 5VSV

  • PubMed Abstract: 

    Inosine 5'-monophosphate dehydrogenase (IMPDH) is a promising antibiotic target. This enzyme catalyzes the NAD-dependent oxidation of inosine 5'-monophosphate (IMP) to xanthosine 5'-monophosphate (XMP), which is the rate-limiting step in guanine nucleotide biosynthesis. Bacterial IMPDH-specific inhibitors have been developed that bind to the NAD + site. These inhibitors display varied affinities to different bacterial IMPDHs that are not easily rationalized by X-ray crystal structures of enzyme-inhibitor complexes. Inspection of X-ray crystal structures of 25 enzyme-inhibitor complexes, including 10 newly described, suggested that a mobile active site flap may be a structural determinant of inhibitor potency. Saturation transfer difference NMR experiments also suggested that the flap may contact the inhibitors to varying extents in different IMPDHs. Flap residue Leu413 contacted some inhibitors but was not structured in the crystal structures of other inhibitor complexes. The substitution of Leu413 with Phe or Ala in Bacillus anthracis IMPDH had inhibitor-selective effects, suggesting residue 413 could be a structural determinant of affinity. Curiously, the Ala substitution increased the potency of most inhibitors, even those that contacted Leu413 in the crystal structures. Presteady-state and steady-state kinetics experiments showed that the Leu413Ala substitution had comparable effects on inhibitor binding to the noncovalent E·IMP complex and the covalent intermediate E-XMP*, suggesting that the flap had similar interactions in both complexes. These results demonstrate that contacts do not necessarily indicate favorable interactions, and poorly structured mobile regions should not be discounted when assessing binding determinants.


  • Organizational Affiliation
    • Department of Chemistry, Brandeis University, Waltham, Massachusetts 02454, United States.

Macromolecule Content 

  • Total Structure Weight: 355.64 kDa 
  • Atom Count: 22,377 
  • Modeled Residue Count: 2,865 
  • Deposited Residue Count: 3,248 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Inosine-5'-monophosphate dehydrogenase,Inosine-5'-monophosphate dehydrogenase
A, B, C, D, E
A, B, C, D, E, F, G, H
406Campylobacter jejuni subsp. jejuniCampylobacter jejuni subsp. jejuni CG8486
This entity is chimeric
Mutation(s): 0 
Gene Names: guaBCJ14980A_1064Cj8486_1016
EC: 1.1.1.205

Small Molecules

Ligands 5 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
8L1

Query on 8L1



Download:Ideal Coordinates CCD File
CA [auth F]
HA [auth G]
L [auth B]
LA [auth H]
O [auth C]
CA [auth F],
HA [auth G],
L [auth B],
LA [auth H],
O [auth C],
Q [auth D],
T [auth D],
W [auth E]
N-{4-chloro-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]phenyl}-N'-(2-{3-[(1E)-N-hydroxyethanimidoyl]phenyl}propan-2-yl)urea
C22 H20 Cl F3 N4 O2 S
RTMPYAODZXTXJR-PNQUVVCRSA-N
IMP

Query on IMP



Download:Ideal Coordinates CCD File
BA [auth F]
GA [auth G]
I [auth A]
K [auth B]
KA [auth H]
BA [auth F],
GA [auth G],
I [auth A],
K [auth B],
KA [auth H],
N [auth C],
S [auth D],
V [auth E]
INOSINIC ACID
C10 H13 N4 O8 P
GRSZFWQUAKGDAV-KQYNXXCUSA-N
EDO

Query on EDO



Download:Ideal Coordinates CCD File
DA [auth F],
EA [auth F],
U [auth D],
X [auth E],
Y [auth E]
1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
IPA

Query on IPA



Download:Ideal Coordinates CCD File
IA [auth G]ISOPROPYL ALCOHOL
C3 H8 O
KFZMGEQAYNKOFK-UHFFFAOYSA-N
K

Query on K



Download:Ideal Coordinates CCD File
AA [auth F]
FA [auth G]
J [auth A]
JA [auth H]
M [auth B]
AA [auth F],
FA [auth G],
J [auth A],
JA [auth H],
M [auth B],
P [auth C],
R [auth D],
Z [auth E]
POTASSIUM ION
K
NPYPAHLBTDXSSS-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free:  0.213 (Depositor), 0.214 (DCC) 
  • R-Value Work:  0.172 (Depositor), 0.174 (DCC) 
  • R-Value Observed: 0.174 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 98.441α = 90
b = 141.281β = 94.36
c = 121.061γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-3000data reduction
HKL-3000data scaling
HKL-3000phasing
MOLREPphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United States--

Revision History  (Full details and data files)

  • Version 1.0: 2017-03-01
    Type: Initial release
  • Version 1.1: 2017-09-20
    Changes: Author supporting evidence
  • Version 1.2: 2020-01-01
    Changes: Author supporting evidence
  • Version 1.3: 2023-10-04
    Changes: Data collection, Database references, Derived calculations, Refinement description
  • Version 1.4: 2026-03-25
    Changes: Database references, Structure summary